Device Trial Radar · NCT03340142
VIVO™ Accuracy Study
Last checked: Nov 20, 2026Latest source record: Nov 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
45
Actual
Start
Jan 29, 2018
Primary completion
Sep 4, 2018
Study completion Nov 1, 2018
Sponsor
- Lead sponsor
- Catheter Precision. Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 13, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-center study designed to assess the accuracy of VIVO™ in determining the location of a PVC/VT foci in comparison to an electroanatomical mapping system.
Conditions
- Premature Ventricular Contraction
- Ventricular Tachycardia
Interventions
VIVO™Device
Diagnose the area of a PVC or VT onset
Primary outcomes
What the sponsor says the trial is designed to measure.
- Accuracy of correctly identifying PVC or VT originTime frame: 1 Day
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
University of Iowa
Iowa City, Iowa
Johns Hopkins Unveristy
Baltimore, Maryland
Medical Unversity of South Carolina
Charleston, South Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.